Gold-associated thrombocytopenia. Report six cases.
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006051:Aurothioglucose / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets / Q000032:analysis; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D004112:Dimercaprol / Q000008:administration & dosage; D004342:Drug Hypersensitivity / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006046:Gold / Q000009:adverse effects*; D006801:Humans; D007111:Immunity, Cellular; D008074:Lipoproteins / Q000032:analysis; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy; D013925:Thromboplastin / Q000032:analysis
D001779:Blood Coagulation Factors; D008074:Lipoproteins; D004112:Dimercaprol; D006051:Aurothioglucose; D006046:Gold; D013925:Thromboplastin; D011241:Prednisone